The former vice chancellor for undergraduate and graduate education will leverage more than 30 years of experience at the Institute to oversee MIT’s research activities.
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
An online model enables users to calculate the least-cost strategy for a specific regional grid under various assumptions; outcomes vary widely from region to region.